Effect of chronic magnesium supplementation on magnesium distribution in healthy volunteers evaluated by 31P-NMRS and ion selective electrodes

British Journal of Clinical Pharmacology

Volumn 48, Issue 5, 1999, Pages 655-662

  Wary, C ^b   Brillault Salvat, C ^a   Bloch, G ^a   Leroy Willig, A ^b   Roumenov, D ^a   Grognet, J M ^a   Leclerc, J H ^c   Carlier, P G ^a  

^a DIF   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Brain; Dietary supplements; Erythrocytes; Ion selective electrode; Magnesium; Nuclear magnetic resonance; Plasma; Skeletal muscle

Indexed keywords

MAGNESIUM; MAGNESIUM LACTATE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CELL LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER PROGRAM; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG BRAIN LEVEL; DRUG DISTRIBUTION; DRUG URINE LEVEL; ERYTHROCYTE; HEART RATE; HUMAN; HUMAN EXPERIMENT; ION SELECTIVE ELECTRODE; MALE; MUSCLE LEVEL; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SKELETAL MUSCLE; SYSTOLIC BLOOD PRESSURE;

ADULT; ALGORITHMS; BLOOD CHEMICAL ANALYSIS; BLOOD PRESSURE; BRAIN; DIET; DOUBLE-BLIND METHOD; ERYTHROCYTES; HEART RATE; HUMANS; MAGNESIUM; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MUSCLE, SKELETAL; REPRODUCIBILITY OF RESULTS; TABLETS; TISSUE DISTRIBUTION;

EID: 0032707557     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2125.1999.00063.x     Document Type: Article

References (43)

1. 1 Elin RJ. Magnesium: the fifth but forgotten electrolyte. Am J Clin Pathol 1994; 102: 616-622.
2. 2 Becchi MA, Borella P, Michelini N. Effects of oral magnesium supplementation on plasma and erythrocytes levels of the cation during maximal effort. Med Dello Sport 1990; 43: 231-239.
3. 3 Borella P, Ambrosini G, Concari M, Bargellini A. Is magnesium content in erythrocytes suitable for evaluating cation retention after oral physiological supplementation in marginally magnesium-deficient subjects? Magnes Res 1993; 6: 149-153.
4. 4 Desbiens NA, Marx JJJ, Haas RG, Reinhart RA. Can the magnesium content of mononuclear blood cells be altered by oral magnesium supplementation? Clin Biochem 1992; 25: 289-292.
5. 5 Howard JM, Davies S, Hunnisett A. Red cell magnesium and glutathione peroxidase in infertile women - effects of oral supplementation with magnesium and selenium. Magnes Res 1994; 7: 49-57.
6. 6 Terblanche S, Noakes TD, Dennis SC, Marais D, Eckert M. Failure of magnesium supplementation to influence marathon running performance or recovery in magnesium-replete subjects. Int J Sport Nutr 1992; 2: 154-164.
7. 7 Elin RJ. Status of the determination of magnesium in mononuclear blood cells in humans. Magnesium 1988; 7: 300-305.
8. 8 Sjogren A, Floren CH, Nilsson A. Magnesium and potassium status in healthy subjects as assessed by analysis of magnesium and potassium in skeletal muscle biopsies and magnesium in mononuclear cells. Magnesium 1987; 6: 91-99.
9. 9 Dyckner T, Wester PO. Skeletal muscle magnesium and potassium determinations: correlation with lymphocyte contents of magnesium and potassium. J Am Coll Nutr 1985; 4: 619-625.
10. 10 Ryschon TW, Rosenstein DL, Rubinow DR, Niemela JE, Elin RJ, Balaban RS. Relationship between skeletal muscle intracellular ionized magnesium and measurements of blood magnesium. J Lab Clin Med 1996; 127: 207-213.
11. 31P-NMR spectroscopy. In Current Research in Magnesium, eds. Halpern MJ, Durlach J. London: John Libbey 1996 25-26.
12. 12 Rosenstein DL, Ryschon TW, Niemela JE, Elin RJ, Balaban RS, Rubinow DR. Skeletal muscle intracellular ionized magnesium measured by 31P-NMR spectroscopy across the menstrual cycle. J Am Coll Nutr 1995; 14: 486-490.
13. 13 Moller JB, Klaaborg KE, Alstrup P, Arendrup H, Klitgard NA, Pedersen KE. Magnesium content of the human heart. Scand J Thorac Cardiovasc Surg 1991; 25: 155-158.
14. 14 Ralston MA, Murnane MR, Kelley RE, Altschuld RA, Unverferth DV, Leier CV. Magnesium content of serum, circulating mononuclear cells, skeletal muscle, and myocardium in congestive heart failure. Circulation 1989; 80: 573-580.
15. 15 Reinhart RA, Marx JJJ, Broste SK, Haas RG. Myocardial magnesium: relation to laboratory and clinical variables in patients undergoing cardiac surgery. J Am Coll Cardiol 1991; 17: 651-656.
16. 16 Camara EJ, Cruz TR, Nassri JM, Rodrigues LE. Muscle magnesium content and cardiac arrhythmias during treatment of congestive heart failure due to chronic chagasic cardiomyopathy. Braz J Med Biol Res 1986; 19: 49-58.
17. 17 Resnick LM, Altura BT, Gupta RK, Laragh JH, Alderman MH, Altura BM. Intracellular and extracellular magnesium depletion in type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 1993; 36: 767-770.
18. 18 Altura BT, Memon ZI, Zhang A, et al. Low levels of serum ionized magnesium are found in patients early after stroke which result in rapid elevation in cytosolic free calcium and spasm in cerebral vascular muscle cells. Neurosci Lett 1997; 230: 37-40.
19. 19 Memon ZI, Altura BT, Benjamin JL, Cracco RQ, Altura BM. Predictive value of serum ionized but not total magnesium levels in head injuries. Scand J Clin Lab Invest 1995; 55: 671-677.
20. 20 Facchinetti F, Sances G, Borella P, Genazzani AR, Nappi G. Magnesium prophylaxis of menstrual migraine: effects on intracellular magnesium. Headache 1991; 31: 298-301.
21. 21 Durlach J, Bac P, Durlach V, Bara M, Guiet-Bara A. Neurotic, neuromuscular and autonomic nervous form of magnesium imbalance. Magnes Res 1997; 10: 169-195.
22. 22 Chen W, Ackerman JJ. Localized 13C-[1H] NMR. of rat liver in vivo using surface-spoiling gradients. NMR Biomed 1989; 2: 267-273.
23. 23 Leclerc JH. The pseudo-Wigner distribution of double and triple resonances. J Magn Reson 1992; 100: 171-182.
24. 24 Halvorson HR, Vande Linde AM, Helpern JA, Welch KM. Assessment of magnesium concentrations by 31P NMR in vivo. NMR Biomed 1992; 5: 53-58.
25. 25 Leclerc JHJ, Wary C, Carlier PG. Determination of intracellular magnesium concentration by P 31 nuclear magnetic resonance spectroscopy-a new quantification technique based on the Wigner distribution. In Advances in Magnesium Research. 1. Magnesium in Cardiology, Ed Smetana R, London: John Libbey, 1997: 577-585.
26. 26 Carlier PG, Bidault N, Wary C, Jehenson P, Leroy Willig A, Bloch G. A reproducibility study of magnesium free intracellular concentration in human skeletal muscle by P31 NMR spectroscopy. Workshop on Magnetic Resonance Imaging and Spectroscopy of Muscle, Liverpool 1994 P25.
27. 27 Li HY, Quamme GA. Caffeine decreases intracellular free Mg2+ in isolated adult rat ventricular myocytes. Biochim Biophys Acta 1997; 1355: 61-68.
28. 28 Weller E, Bachert P, Meinck HM, Friedmann B, Bartsch P, Mairbaurl H. Lack of effect of oral Mg-supplementation on Mg in serum, blood cells, and calf muscle. Med Sci Sports Exerc 1998; 30: 1584-1591.
29. 29 Paolisso G, Scheen A, Cozzolino D, et al. Changes in glucose turnover parameters and improvement of glucose oxidation after 4-week magnesium administration in elderly noninsulin-dependent (type II) diabetic patients. J Clin Endocrinol Metab 1994; 78: 1510-1514.
30. 30 Paolisso G, Di Maro G, Cozzolino D, et al. Chronic magnesium administration enhances oxidative glucose metabolism in thiazide treated hypertensive patients. Am J Hypertens 1992; 5: 681-686.
31. 31 Paolisso G, Sgambato S, Cambardella A, et al. Daily magnesium supplements improve glucose handling in elderly subjects. Am J Clin Nutr 1992; 55: 1161-1167.
32. 32 Corica F, Allegra A, Di Benedetto A, et al. Effects of oral magnesium supplementation on plasma lipid concentrations in patients with non-insulin-dependent diabetes mellitus. Magnes Res 1994; 7: 43-47.
33. 33 Kisters K, Spieker C, Tepel M, Zidek W. New data about the effects of oral physiological magnesium supplementation on several cardiovascular risk factors (lipids and blood pressure). Magnes Res 1993; 6: 355-360.
34. 34 Dyckner T, Wester PO. Effect of magnesium on blood pressure. Br Med J (Clin Res. eds) 1983; 286: 1847-1849.
35. 35 Motoyama T, Sano H, Fukuzaki H. Oral magnesium supplementation in patients with essential hypertension. Hypertension 1989; 13: 227-232.
36. 36 Widman L, Wester PO, Stegmayr BK, Wirell M. The dose dependent reduction in blood pressure through administration of magnesium. A double blind placebo controlled cross-over study. Am J Hypertens 1993; 6: 41-45.
37. 37 Witteman JC, Grobbee DE, Derkx FH, Bouillon R, de Bruijn AM, Hofman A. Reduction of blood pressure with oral magnesium supplementation in women with mild to moderate hypertension. Am J Clin Nutr 1994; 60: 129-135.
38. 38 Singh RB, Singh NK, Niaz MA, Sharma JP. Effect of treatment with magnesium and potassium on mortality and reinfarction rate of patients with suspected acute myocardial infarction. Int J Clin Pharmacol Ther 1996; 34: 219-225.
39. 39 Hill J, Micklewright A, Lewis S, Britton J. Investigation of the effect of short-term change in dietary magnesium intake in asthma. Eur Respir J 1997; 10: 2225-2229.
40. 40 Gullestad L, Dolva LO, Soyland E, Manger AT, Falch D, Kjekshus J. Oral magnesium supplementation improves metabolic variables and muscle strength in alcoholics. Alcohol Clin Bxp Res 1992; 16: 986-990.
41. 41 Starobrat-Hermelin B, Kozielec T. The effects of magnesium physiological supplementation on hyperactivity in children with attention deficit hyperactiviry disorder (ADHD). Positive response to magnesium oral loading test. Magnes Res 1997; 10: 149-156.
42. 42 Singh RB. Effect of dietary magnesium supplementation in the prevention of coronary heart disease and sudden cardiac death. Magnes Trace Elem 1990; 9: 143-151.
43. 43 Dorup I, Skajaa K, Thybo NK. Oral magnesium supplementation restores the concentrations of magnesium, potassium and sodium potassium pumps in skeletal muscle of patients receiving diuretic treatment. J Intern Med 1993; 233: 117-123.